- Institutional pharmacy Omnicare (NYSE:OCR -3%) signs a new five-year agreement with McKesson (MCK +1.8%) covering the sourcing and distribution of branded, specialty and generic pharmaceuticals. The new contract, which builds on their ten-year partnership, adds generic drugs as part of McKesson's OneStop program.